Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 1712-1716, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menyhart, J.
Right arrow Articles by Grof, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menyhart, J.
Right arrow Articles by Grof, J.

Clinical Chemistry, Vol 27, 1712-1716, Copyright © 1981 by American Association for Clinical Chemistry

Many hitherto unknown peptides are principal constituents of uremic "middle molecules"

J Menyhart and J Grof

The aim of the present investigation was to collect information on the molecular composition of uremic "middle molecules," the 500-5000 molecular-mass serum constituents assumed to be involved in the molecular etiology of uremic intoxication. For this purpose, three fractions of serum containing such molecules were separated by cation- exchange column chromatography. These fractions absorb at 240 nm and are characteristically increased in chronic uremia. By one-dimensional paper chromatography of these fractions it was demonstrated that each could be resolved into at least seven (altogether, 21) ninhydrin- positive subfractions. These, like the original fractions, yielded amino acids on acid hydrolysis. The qualitative amino acid composition of the subfractions differed substantially, both from each other and from that of 31 known peptides with which they were compared. We conclude that hitherto unknown peptides with only limited diffusibility through hemodialysis membranes constitute the main bulk of uremic middle molecules.


The following articles in journals at HighWire Press have cited this article:


Home page
 ANN INTERN MEDHome page
S. W. GRAVES, B. BROWN, and R. VALDES Jr.
An Endogenous Digoxin-Like Substance in Patients with Renal Impairment
Ann Intern Med, November 1, 1983; 99(5): 604 - 608.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.